Quick Takeaways
- Mark S. Levine has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,124,353.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Mark S. Levine
- Location
- Waltham, MA
- Summary
- The estimated net worth of Mark S. Levine is at least $8,124,353 dollars as of 05 Mar 2026. Mark S. Levine is the Chief Legal Officer of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $8.12M.
- Signature
- /s/ Mark S. Levine
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mark S. Levine and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunovant, Inc. ($8,124,353).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Mark S. Levine
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Chief Legal Officer | $8,124,353 | 20 Nov 2024 | ||
| MASS | 908 Devices Inc. | Chief Legal and Admin. Officer | 26 Feb 2026 | |||
| FLXN | Flexion Therapeutics Inc | General Counsel | 19 Nov 2021 |
Insider Transactions Reported by Mark S. Levine:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.